Protara Therapeutics, Inc. (TARA)
TARA Stock Price Chart
Explore Protara Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze TARA price movements and trends.
TARA Company Profile
Discover essential business fundamentals and corporate details for Protara Therapeutics, Inc. (TARA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Oct 2014
Employees
28.00
Website
https://www.protaratx.comCEO
Jesse Shefferman
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
TARA Financial Timeline
Browse a chronological timeline of Protara Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.39.
Earnings released on 11 Aug 2025
EPS came in at -$0.35 surpassing the estimated -$0.43 by +18.60%.
Earnings released on 8 May 2025
EPS came in at -$0.29 surpassing the estimated -$0.47 by +38.30%.
Earnings released on 5 Mar 2025
EPS came in at -$0.48 surpassing the estimated -$0.57 by +15.79%.
Earnings released on 12 Nov 2024
EPS came in at -$0.50 matching the estimated -$0.50.
Earnings released on 6 Aug 2024
EPS came in at -$0.45 surpassing the estimated -$0.82 by +45.12%.
Earnings released on 2 May 2024
EPS came in at -$0.97 surpassing the estimated -$0.99 by +2.02%.
Earnings released on 13 Mar 2024
EPS came in at -$0.90 surpassing the estimated -$1.03 by +12.62%, while revenue for the quarter reached $1.21M .
Earnings released on 3 Nov 2023
EPS came in at -$0.87 surpassing the estimated -$1.10 by +20.91%.
Earnings released on 3 Aug 2023
EPS came in at -$1.00 falling short of the estimated -$0.97 by -3.09%.
Earnings released on 4 May 2023
EPS came in at -$0.80 surpassing the estimated -$1.00 by +20.00%.
Earnings released on 8 Mar 2023
EPS came in at -$0.84 falling short of the estimated -$0.77 by -9.09%.
Earnings released on 3 Nov 2022
EPS came in at -$0.68 surpassing the estimated -$0.85 by +20.00%.
Earnings released on 9 Aug 2022
EPS came in at -$0.80 surpassing the estimated -$1.13 by +29.20%.
Earnings released on 5 May 2022
EPS came in at -$0.96 surpassing the estimated -$1.09 by +11.93%.
Earnings released on 9 Mar 2022
EPS came in at -$0.91 surpassing the estimated -$0.94 by +3.19%.
Earnings released on 4 Nov 2021
EPS came in at -$0.96 surpassing the estimated -$1.15 by +16.52%.
Earnings released on 5 Aug 2021
EPS came in at -$1.14 matching the estimated -$1.14.
Earnings released on 6 May 2021
EPS came in at -$1.20 falling short of the estimated -$0.92 by -30.43%.
Earnings released on 11 Mar 2021
EPS came in at -$0.79 falling short of the estimated -$0.42 by -88.10%.
Earnings released on 12 Nov 2020
EPS came in at -$1.26 falling short of the estimated -$0.62 by -103.23%.
TARA Stock Performance
Access detailed TARA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.